Clinical Trials for Facio-Scapulo-Humeral Dystrophy

A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD

NCT ID: NCT07038200

This clinical trial is studying a new treatment called Del-brax (also known as AOC 1020) for people with facioscapulohumeral muscular dystrophy (FSHD), a condition that causes muscle weakness, espe...

Study of ARO-DUX4 in Adult Patients With Facioscapulohumeral Muscular Dystrophy Type 1

NCT ID: NCT06131983

This clinical trial is studying a new treatment called ARO-DUX4 for adults with Facioscapulohumeral Muscular Dystrophy Type 1 (FSHD1), a condition that affects muscle strength and movement. The mai...

Phase 2 Open-label Extension Study of AOC 1020 in Participants with Facioscapulohumeral Muscular Dystrophy (FSHD)

NCT ID: NCT06547216

Rehabilitation in Muscular Dystrophies From the Hospital Facility to the Home: Pilot Project [RIMUDI]

NCT ID: NCT06378203

The RIMUDI trial is studying how rehabilitation can benefit people with muscular dystrophies, specifically conditions like Limb Girdle Muscular Dystrophy, Facio-Scapulo-Humeral Dystrophy, and Becke...

FSHD Molecular Characterization

NCT ID: NCT06096441

This clinical trial, called the FSHD Molecular Characterization, is focused on studying a condition known as Facio-Scapulo-Humeral Dystrophy (FSHD). The goal of the trial is to better understand th...